Found: 24
Select item for more details and to access through your institution.
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1746, doi. 10.1002/ajh.27382
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00906-7
- By:
- Publication type:
- Article
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1501, doi. 10.1007/s00277-023-05188-4
- By:
- Publication type:
- Article
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1474, doi. 10.4149/neo_2022_220813N827
- By:
- Publication type:
- Article
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5165, doi. 10.3390/cancers14205165
- By:
- Publication type:
- Article
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102535
- By:
- Publication type:
- Article
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 954, doi. 10.1111/bjh.17925
- By:
- Publication type:
- Article
OAB-046: COVID-19 infection in multiple myeloma patients – retrospective analysis of 371 Czech patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S29, doi. 10.1016/S2152-2650(21)02120-0
- By:
- Publication type:
- Article
P-210: Oral ixazomib (Ixa), IV daratumumab (Dara), and dexamethasone (dex; IDd) in relapsed/refractory multiple myeloma (RRMM) patients (pts) with 1–3 prior therapies: phase 2 study interim analysis (IA).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02337-5
- By:
- Publication type:
- Article
Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 466, doi. 10.1111/ejh.13683
- By:
- Publication type:
- Article
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real‐world confirmation.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 5, p. e244, doi. 10.1111/ijlh.13460
- By:
- Publication type:
- Article
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Rapidly progressing acute myeloid leukemia with KAT6A-LEUTX fusion in a newborn.
- Published in:
- 2020
- By:
- Publication type:
- case study
Identification of patients with smouldering multiple myeloma at ultra‐high risk of progression using serum parameters: the Czech Myeloma Group model.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 189, doi. 10.1111/bjh.16572
- By:
- Publication type:
- Article
Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01665
- By:
- Publication type:
- Article
Urine immunofixation is not necessary for CR definition in myeloma patients with complete M protein molecule.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e180, doi. 10.1016/j.clml.2019.09.302
- By:
- Publication type:
- Article
Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e271, doi. 10.1016/j.clml.2019.09.448
- By:
- Publication type:
- Article
Registry of Monoclonal Gammopathies (RMG) - the monitored real-world database of the Czech Myeloma Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e324, doi. 10.1016/j.clml.2019.09.533
- By:
- Publication type:
- Article
Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 8, p. 4132, doi. 10.1002/cam4.1620
- By:
- Publication type:
- Article
Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients.
- Published in:
- Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2018, v. 31, n. 3, p. 213, doi. 10.14735/amko2018213
- By:
- Publication type:
- Article
Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 2, p. 119, doi. 10.1111/ejh.12556
- By:
- Publication type:
- Article
Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123866
- By:
- Publication type:
- Article
The first case of fatal pneumonia caused by Panton-Valentine leukocidin-producing Staphylococcus aureus in an infant in the Czech Republic.
- Published in:
- Folia Microbiologica, 2013, v. 58, n. 3, p. 225, doi. 10.1007/s12223-012-0200-z
- By:
- Publication type:
- Article
Fatal case of diarrhea-associated hemolytic uremic syndrome with severe neurologic involvement.
- Published in:
- Pediatrics International, 2012, v. 54, n. 1, p. 166, doi. 10.1111/j.1442-200X.2011.03533.x
- By:
- Publication type:
- Article